Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia ; volume:9 ; number:1 ; day:02 ; month:9 ; year:2009 ; pages:1-9 ; date:12.2009
BMC psychiatry ; 9, Heft 1 (02.9.2009), 1-9, 12.2009
- Creator
-
Faries, Douglas E.
- Contributor
-
Ascher-Svanum, Haya
Nyhuis, Allen W.
Kinon, Bruce J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-9-54
- URN
-
urn:nbn:de:1111-2016030428952
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Faries, Douglas E.
- Ascher-Svanum, Haya
- Nyhuis, Allen W.
- Kinon, Bruce J.
- SpringerLink (Online service)
Other Objects (12)
Commentary on strategies for switching antipsychotics
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review
Predictors of antipsychotics switching among ambulatory patients with schizophrenia in Ethiopia: a multicenter hospital-based cross-sectional study
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Commentary on strategies for switching antipsychotics
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review
Predictors of antipsychotics switching among ambulatory patients with schizophrenia in Ethiopia: a multicenter hospital-based cross-sectional study
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
Commentary on strategies for switching antipsychotics
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review
Predictors of antipsychotics switching among ambulatory patients with schizophrenia in Ethiopia: a multicenter hospital-based cross-sectional study
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series